Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35.5Revenue (TTM) $M20.6Net Margin (%)-30.8Altman Z-Score-5.0
Enterprise Value $M2.5EPS (TTM) $-0.7Operating Margin %-32.0Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-30.8Higher ROA y-yY
Price/Book0.910-y EBITDA Growth Rate %-20.4Quick Ratio12.4Cash flow > EarningsY
Price/Sales1.75-y EBITDA Growth Rate %-14.6Current Ratio12.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-12.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-14.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M9.2ROIC % (ttm)-74.6Gross Margin Increase y-yY

Gurus Latest Trades with VICL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VICLJohn Rogers 2016-06-30 Reduce$3.61 - $4.72
($4.08)
$ 3.89-5%Reduce -4.48%528,991
VICLJohn Rogers 2016-03-31 Reduce-0.01%$3.05 - $4.53
($3.66)
$ 3.896%Reduce -20.34%553,776
VICLJohn Rogers 2015-12-31 Reduce$3.5 - $5.34
($4.14)
$ 3.89-6%Reduce -6.51%695,218
VICLJohn Rogers 2015-09-30 Reduce$4.58 - $7
($6.13)
$ 3.89-37%Reduce -0.32%743,627
VICLJohn Rogers 2015-06-30 Add$7 - $14.8
($9.95)
$ 3.89-61%Add 7.21%746,052
VICLJohn Rogers 2015-03-31 Add$8.55 - $11.7
($10.16)
$ 3.89-62%Add 7.34%695,895
VICLJohn Rogers 2014-12-31 Add0.01%$10 - $12.5
($11.23)
$ 3.89-65%Add 10.25%648,322
VICLGeorge Soros 2014-09-30 Sold Out $11.2 - $13.1
($12.34)
$ 3.89-68%Sold Out0
VICLJohn Rogers 2014-09-30 Add$11.2 - $13.1
($12.34)
$ 3.89-68%Add 1.48%588,071
VICLGeorge Soros 2014-06-30 Buy $11.2 - $13.5
($11.96)
$ 3.89-67%New holding5,818
VICLJohn Rogers 2014-03-31 Reduce-0.02%$11.9 - $17.2
($14.17)
$ 3.89-73%Reduce -17.94%579,509
VICLJohn Rogers 2013-12-31 Add0.03%$10.15 - $14.9
($12.01)
$ 3.89-68%Add 39.31%706,210
VICLJohn Rogers 2013-09-30 Reduce$11.9 - $42.6
($23.82)
$ 3.89-84%Reduce -1.28%506,924
VICLJohn Rogers 2013-06-30 Add0.13%$29.3 - $42.2
($35.16)
$ 3.89-89%Add 93.26%513,482
VICLJohn Rogers 2013-03-31 Add0.08%$30.8 - $42.6
($35.55)
$ 3.89-89%Add 71.60%265,697
VICLJohn Rogers 2012-12-31 Add0.03%$27.4 - $43.2
($33.03)
$ 3.89-88%Add 49.50%154,836
VICLJohn Rogers 2012-09-30 Add0.01%$33 - $45.8
($36.95)
$ 3.89-89%Add 8.77%103,566
VICLJohn Rogers 2012-06-30 Add0.01%$28 - $36
($30.66)
$ 3.89-87%Add 8.55%95,219
VICLJohn Rogers 2012-03-31 Add0.01%$30.2 - $44.9
($34.52)
$ 3.89-89%Add 26.34%87,719
VICLJohn Rogers 2011-12-31 Add$22.9 - $46.9
($36.17)
$ 3.89-89%Add 7.48%69,430
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VICL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VICL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2016-07-11Sell54$4.46-12.78view
MERTON ROBERT CDirector 2016-06-14Buy9,000$4.34-10.37view
SAMANT VIJAY BPresident & CEO 2016-06-09Buy15,700$4.72-17.58view
DOUGLAS R GORDONDirector 2016-06-06Buy10,078$4.41-11.79view
LYONS GARY ADirector 2016-06-03Buy7,078$4.39-11.39view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2016-03-15Sell875$4.1-5.12view
SAMANT VIJAY BPresident & CEO 2016-03-03Sell3,750$3.68.06view
Ramos Anthony AlanVP, Chief Accounting Officer 2016-02-19Sell750$3.317.88view
Ramos Anthony AlanVP, Chief Accounting Officer 2016-01-25Sell19$3.511.14view
SAMANT VIJAY BPresident & CEO 2016-01-12Sell5,974$3.511.14view

Quarterly/Annual Reports about VICL:

News about VICL:

Articles On GuruFocus.com
CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016 
Red Hat (RHT) and Five Below (FIVE) Strong Performance Metrics; Vical (VICL) Targets Multi-billion S Mar 26 2015 
John Rogers Comments on Vical Feb 26 2014 
Kids Decide on Dolls or Devices - JAKK, Others 70% Off Sep 17 2013 
Weekly CFO Buys Highlight: VICL, EXA, UCBA, YORW, MGI Jan 21 2013 
Vical Inc. Insiders Boost Shares after Company’s NASDAQ Listing Gets Upgrade Jan 17 2013 
Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
Vical Inc. (VICL) CEO Vijay B Samant buys 1,000 Shares Jan 20 2011 
Vical Inc. Reports Operating Results (10-Q) Aug 06 2010 
Vical Inc. Reports Operating Results (10-Q) May 07 2010 

More From Other Websites
VICAL INC Financials Aug 19 2016
Vical, Inc. :VICL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
Vical reports 2Q loss Aug 09 2016
Vical reports 2Q loss Aug 09 2016
Vical Reports Second Quarter 2016 Financial Results Aug 09 2016
VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 09 2016
Vical Reports Second Quarter 2016 Financial Results Aug 09 2016
Investor Calendar Invites You to the Vical Second Quarter 2016 Earnings Webcast Live on Tuesday,... Aug 08 2016
VICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Aug 03 2016
Vical Announces News Release and Conference Call Schedule for Second Quarter 2016 Financial Results Aug 02 2016
Vical Announces News Release and Conference Call Schedule for Second Quarter 2016 Financial Results Aug 02 2016
Vical Announces $7.8 Million Equity Investment by Partner, AnGes MG Aug 01 2016
Vical Announces $7.8 Million Equity Investment by Partner, AnGes MG Aug 01 2016
ETF’s with exposure to Vical, Inc. : July 26, 2016 Jul 26 2016
Vical (VICL) Reports Phase I/II Data on Genital Herpes Vaccine Jun 21 2016
Vical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in... Jun 20 2016
Vical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in... Jun 20 2016
Vical to Present HSV-2 Phase 1/2 Data at June ASM Microbe/ICAAC 2016 Conference Jun 13 2016
Vical to Present HSV-2 Phase 1/2 Data at June ASM Microbe/ICAAC 2016 Conference Jun 13 2016
Vical Provides VL-2397 Updates at BIO International Convention May 31 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)